|9 Months Ended|
Sep. 30, 2022
NOTE 5 – COMMON STOCK
In August 2022, the Company issued an aggregate of shares of common stock to its officers, employees and consultants as part of the Company’s Employee Retention Program and the Company’s 2016 Omnibus Incentive Plan. The shares of common stock had an aggregate grant date fair value of $ based on the closing price of the Company’s common stock on the grant date of the awards.
During the three and nine-month periods ended September 30, 2022 and September 30, 2021, the Company had stock-based compensation expense of $ and , respectively.
No definition available.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef